PET Probe Detects Dying Tumor Cells
Noninvasive biomarkers that detect programmed cell death – apoptosis – would be valuable for predicting early responses to anticancer therapies and for improving drug discovery. Potential targets for molecular imaging of apoptosis include caspase enzymes, which play essential roles in apoptotic signaling pathways. H.
VICC Debuts Novel Neuroendocrine Tumor Treatment
Eric Liu, M.D., assistant professor of Surgery and Radiology and Radiological Sciences, is the principal investigator at Vanderbilt for the trial, dubbed NETTER-1.
“Neuroendocrine tumors are a difficult type of cancer to take care of because they have unusual traits,” Liu said. “Not only do these tumors grow but they also secrete hormones, which can create lots of symptoms. They can be quite difficult to diagnose and require a multi-modal approach to care.”
Daniel Arteaga awarded RSNA Research Medical Student Grant
Daniel Arteaga, B.A., Class of 2015 Vanderbilt Medical School, has recently been named a recipient of the Research Medical Student Grant awarded by the Radiological Society of North America (RSNA). This grant is awarded on an annual basis to medical students pursuing research in the field of radiology.
Radiology welcomes Adam Guttentag, MD
Adam Guttentag, M.D., has joined the faculty in the Chest and Body Imaging sections of the Department of Radiology effective April 1, 2014.
Dr. Guttentag graduated from the University of Pennsylvania School of Medicine in 1985. He served a transitional year at Mercy Hospital Pittsburgh, PA, and was a resident in Diagnostic Radiology at Boston University Medical Center, graduating in 1990. He was a Thoracic Radiology fellow at Massachusetts General Hospital in 1990-91. He was given board certification in Diagnostic Radiology by the ABR in 1990.
